Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

carmustine, poliferprosan 20 drug combination × Myeloid × 30 days × Clear all

Sponsor

Cancer Type

Interventions

venetoclax 20 Azacitidine 19 Specimen Handling 16 fludarabine 15 Biopsy 15 Cyclophosphamide 14 fludarabine phosphate 11 Whole-Body Irradiation 9 Injections 8 Decitabine 8 Cytarabine 8 Busulfan 8 decitabine and cedazuridine drug combination 7 Stem Cell Transplantation 7 Mycophenolic Acid 7 Melphalan 7 Granulocyte Colony-Stimulating Factor 7 ruxolitinib 5 X-Rays 5 Filgrastim 5 Tacrolimus 4 Methotrexate 4 Mesna 4 Magnetic Resonance Spectroscopy 4 Cyclosporins 4 Cyclosporine 4 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 4 olutasidenib 3 asciminib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡